Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer
Author:
Funder
Department of Biotechnology, Govt. of India
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference81 articles.
1. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells;Rybak;Biochim. Biophys. Acta (BBA)-Mol. Cell Res.,2011
2. Prostate cancer epidemiology;Gronberg;Lancet,2003
3. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc;Qu;Biomed. Pharmacother.,2018
4. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells;Le Broc-Ryckewaert;Int. J. Pharm.,2013
5. Advances in cancer stem cell targeting: how to strike the evil at its root;Putzer;Adv. Drug Deliv. Rev.,2017
Cited by 91 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dual-targeting galactose-functionalized hyaluronic acid modified lipid nanoparticles delivering silybin for alleviating alcoholic liver injury;International Journal of Pharmaceutics;2024-09
2. Versatile Applications of Organic Polymer and Their Prospects;Organic Polymers in Energy‐Environmental Applications;2024-08-23
3. Factors affecting response variables with emphasis on drug release and loading for optimization of liposomes;Artificial Cells, Nanomedicine, and Biotechnology;2024-06-04
4. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies – Spotlight on prostate and colorectal cancer;Experimental and Molecular Pathology;2024-06
5. Using nanotechnology to progress the utilization of marine natural products in combating multidrug resistance in cancer: A prospective strategy;Journal of Biochemical and Molecular Toxicology;2024-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3